Today’s upgraded profit guidance explains the director buying on market.
It’s a bit fishy the directors buying between half year results and now this profit upgrade a month later. Will take their word on that one.
- Forums
- ASX - By Stock
- BOL
- So much insider buying -
So much insider buying -, page-2
Featured News
Add BOL (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.0¢ |
Change
-0.005(3.45%) |
Mkt cap ! $59.03M |
Open | High | Low | Value | Volume |
14.5¢ | 14.5¢ | 13.5¢ | $47.55K | 340.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 855701 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 201387 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 855701 | 0.135 |
4 | 88041 | 0.130 |
2 | 206000 | 0.125 |
2 | 8340 | 0.120 |
1 | 19317 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 201387 | 2 |
0.145 | 945505 | 8 |
0.150 | 308222 | 6 |
0.155 | 456344 | 5 |
0.160 | 527611 | 4 |
Last trade - 15.52pm 10/10/2024 (20 minute delay) ? |
Featured News
BOL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online